Study highlights bias in ACL injury rate metrics for women athletes

A new study by the Harvard GenderSci Lab in the British Journal of Sports Medicine reveals systematic biases in a key metric used in estimates of sex disparities in ACL injury rates in sports.

Fauci: When Confronted With Misinformation, Stick to the Science

While public health professionals don’t get formal training on how to operate in highly politically charged and divisive environments, the best thing to do is

March 28, 2024

Merck partners with Hengrui in deal worth up to $1.48bn – Pharmaceutical Technology

The deal gives Merck the worldwide rights for both assets outside of China. Image credit: Shutterstock/OleksSH. Merck KGaA (Merck) is expanding its oncology portfolio after

October 30, 2023

GC Biopharma, Eubiologics enter deal to produce cholera vaccine

The companies will jointly manufacture the cholera vaccine from the first half of 2024. Credit: Andrey_Popov / Shutterstock.com. South Korean biopharmaceutical firm GC Biopharma has

August 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.